Remembering Fitzhugh Mullan, MD, PhD

July 31, 2020
Fitzhugh Mullan, MD, PhD

George Washington University (GW) Professor of Health Policy Management and of Pediatrics Fitzhugh Mullan, MD, PhD, died of lung cancer on Nov. 29, 2019, at age 77.

“He leaves an incredible legacy as a teacher, mentor, clinician, and leader,” said Jeffrey S. Akman, MD ’81, RESD ’85, former vice president for health affairs, Walter A. Bloedorn Professor of Administrative Medicine, and dean of GW School of Medicine and Health Sciences (SMHS). “His passion for medicine and health and his positive energy, will certainly be missed.”

Mullan joined SMHS in 1996, as professor of pediatrics, ultimately becoming the Murdock Head Professor of Medicine at SMHS, and professor of health policy and management at the Milken Institute School of Public Health at GW. 

In 2011, the National Institutes of Health tapped GW to serve as the coordinating center of its Medical Education Partnership Initiative, with Mullan at the helm. The $12.5-million, five-year project sought to increase medical education capacity at 12 participating medical schools in sub-Saharan Africa, enhancing the quantity, quality, and retention of the graduates. 

In 2015, Mullan co-founded GW’s Health Workforce Institute to study and strengthen health workforce policies in the United States and around the world. In 2019, the institute was renamed the Fitzhugh Mullan Institute for Health Workforce Equity. 

Mullan was first diagnosed with cancer in 1975. Seven years later he published his first book, “Young Man’s Cancer,” about his experiences as a physician battling cancer and gaining a new perspective on the medical care patients receive along the path to recovery. He went on to become the founding president of the National Coalition for Cancer Survivorship.

Mullan is survived by his wife, Irene Dankwa-Mullan; daughters, Meghan and Caitlin; son, Jason; and stepdaughter, Perpetua. 

Latest News

March 2, 2021
The George Washington University is participating in another COVID-19 vaccine clinical trial. GW was selected as one of approximately 25 sites in the United States to launch a Phase II study for the Sanofi COVID-19 adjuvanted recombinant protein-based COVID-19 vaccine candidate.
February 25, 2021
The George Washington University (GW) Office of the Vice President for Research and the GW School of Medicine and Health Sciences gave COVID-19 research a shot in the arm through the FY21 COVID-19 Research Fund competition.
February 25, 2021
A group of interdisciplinary researchers at the George Washington University received more than $3.3 million in grants for their research on networks within the autonomic nervous system and therapies that may lead to new treatments for heart attack and sleep apnea.